Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.

Some dibenzo compounds might help treat cancer with fewer side effects.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Oral tofacitinib successfully treated total body hair loss in one patient.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.